Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 15, 2022 - Issue
Submit an article Journal homepage
215
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Correlation Between Angiopoietin-Like 3 and Metabolic Markers of Some Lipid and Glucose in Type 2 Diabetes Mellitus Patients at the First Diagnosis

Minh Hoang Thi1 Department of Pathophysiology, Vietnam Military Medical University (VMMU), Ha Noi City, VietnamORCID Iconhttps://orcid.org/0000-0001-7638-0554
ORCID Icon,
Chung Dang Thanh2 Department of Pathology and Forensic Medicine, 103 Military Medical Hospital, Vietnam Military Medical University (VMMU), Ha Noi City, VietnamORCID Iconhttps://orcid.org/0000-0003-2376-1665
ORCID Icon &
Thuan Huynh Quang3 Biochemistry Department, 103 Military Medical Hospital, Vietnam Military Medical University (VMMU), Ha Noi City, VietnamCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0162-171X
ORCID Icon
Pages 3329-3337 | Received 02 Aug 2022, Accepted 14 Oct 2022, Published online: 29 Oct 2022

References

  • Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
  • Parhofer KG. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia. Diabetes Metab J. 2015;39(5):353–362. doi:10.4093/dmj.2015.39.5.353
  • Karpe F, Dickmann JR, Frayn KN. Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes. 2011;60(10):2441–2449. doi:10.2337/db11-0425
  • Dali-Youcef N, Mecili M, Ricci R, Andres E. Metabolic inflammation: connecting obesity and insulin resistance. Ann Med. 2013;45(3):242–253. doi:10.3109/07853890.2012.705015
  • Kadomatsu T, Tabata M, Oike Y. Angiopoietin-like proteins: emerging targets for treatment of obesity and related metabolic diseases. FEBS J. 2011;278(4):559–564. doi:10.1111/j.1742-4658.2010.07979.x
  • Morelli M, Chavez C, Santulli G. Angiopoietin-like proteins as therapeutic targets for cardiovascular disease: focus on lipid disorders. Expert Opin Ther Targets. 2020;24(1):79–88. doi:10.1080/14728222.2020.1707806
  • Christopoulou E, Elisaf M, Filippatos T. Effects of angiopoietin-like 3 on triglyceride regulation, glucose homeostasis, and diabetes. Dis Markers. 2019;2019:1–8. doi:10.1155/2019/6578327
  • Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. 2011;18(2):139–143. doi:10.1097/MED.0b013e3283444b09
  • Zhao D, Yang LY, Wang XH, et al. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients. Cardiovasc Diabetol. 2016;15(1):132. doi:10.1186/s12933-016-0450-1
  • Cinkajzlová A, Mráz M, Lacinová Z, et al. Angiopoietin-like protein 3 and 4 in obesity, type 2 diabetes mellitus, and malnutrition: the effect of weight reduction and realimentation. Nutr Diabetes. 2018;8(1):21. doi:10.1038/s41387-018-0032-2
  • Mehta N, Qamar A, Qu L, et al. Differential association of plasma angiopoietin-like proteins 3 and 4 with lipid and metabolic traits. Arterioscler Thromb Vasc Biol. 2014;34(5):1057–1063. doi:10.1161/ATVBAHA.113.302802
  • Robciuc MR, Tahvanainen E, Jauhiainen M, Ehnholm C. Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample. J Lipid Res. 2010;51(4):824–831. doi:10.1194/jlr.M002618
  • Harada M, Yamakawa T, Kashiwagi R, et al. Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes. PLoS One. 2021;16(7):e0255147. doi:10.1371/journal.pone.0255147
  • Yu CG, Yuan SS, Yang LY, et al. Angiopoietin-like 3 is a potential biomarker for retinopathy in type 2 diabetic patients. Am J Ophthalmol. 2018;191:34–41. doi:10.1016/j.ajo.2018.03.040
  • Wang X, Lv W, Chadwick AC, McDermott-Roe C, Musunuru K. Abstract 532: ANGPTL3 in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol. 2019;39(Suppl_1):A532–A532.
  • American Diabetes Association. Standards of medical care in diabetes-2019 abridged for primary care providers. Clin Diabetes. 2019;37(1):11–34. doi:10.2337/cd18-0105
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883
  • Wang Y, McNutt MC, Banfi S, et al. Hepatic ANGPTL3 regulates adipose tissue energy homeostasis. Proc Natl Acad Sci U S A. 2015;112(37):11630–11635. doi:10.1073/pnas.1515374112
  • Witte N, Muenzner M, Rietscher J, et al. The glucose sensor ChREBP links De Novo lipogenesis to PPARgamma activity and adipocyte differentiation. Endocrinology. 2015;156(11):4008–4019. doi:10.1210/EN.2015-1209
  • Nidhina Haridas PA, Soronen J, Sädevirta S, et al. Regulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by insulin. J Clin Endocrinol Metab. 2015;100(10):E1299–E1307. doi:10.1210/jc.2015-1254
  • Feingold KR. Dyslipidemia in Diabetes. South Dartmouth (MA): MDText.com, Inc.; 2020.
  • Robciuc MR, Maranghi M, Lahikainen A, et al. Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Arterioscler Thromb Vasc Biol. 2013;33(7):1706–1713. doi:10.1161/ATVBAHA.113.301397
  • Tarugi P, Bertolini S, Calandra S. Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia. J Biomed Res. 2019;33(2):73–81. doi:10.7555/JBR.32.20170114

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.